Clinical Trials on 白血病,骨髓,加速期 in United Kingdom
总计2583个结果
-
M.D. Anderson Cancer Center完全的
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteESP Pharma终止
-
Antonio M Jimenez JimenezAbbVie尚未招聘
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of Health招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Brian JonasNational Cancer Institute (NCI); GlycoMimetics Incorporated招聘中
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...招聘中
-
M.D. Anderson Cancer CenterEli Lilly and Company; High Impact Clinical Research Support Program完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute主动,不招人
-
Uma Borate招聘中复发性急性髓性白血病 | 难治性急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | 伴有 KMT2A 重排的急性髓性白血病 | NPM1突变的急性髓性白血病美国
-
Astellas Pharma Global Development, Inc.完全的
-
Eli Lilly and Company完全的
-
Stanford UniversityGenzyme, a Sanofi Company终止
-
Washington University School of MedicineKaryopharm Therapeutics Inc完全的
-
Washington University School of Medicine终止
-
Astellas Pharma Global Development, Inc.招聘中急性髓系白血病 (AML) | 具有 FMS 样酪氨酸激酶 3 (FLT3) 突变/内部串联重复 (ITD) 的急性髓性白血病美国, 加拿大, 德国, 意大利, 西班牙, 英国, 法国
-
Keystone Nano, IncMilton S. Hershey Medical Center; University of Virginia尚未招聘
-
University of Florida终止
-
University of California, San DiegoPfizer; Celgene Corporation完全的
-
University of Alabama at BirminghamGenzyme, a Sanofi Company完全的
-
Shanghai Fosun Pharmaceutical Industrial Development...终止
-
University of Colorado, DenverKaryopharm Therapeutics Inc招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人